Literature DB >> 19261991

Importance of dual induction tests for coronary vasospasm and ventricular fibrillation in patients surviving out-of-hospital cardiac arrest.

Yusuke Takagi1, Satoshi Yasuda, Jun Takahashi, Morihiko Takeda, Masaharu Nakayama, Kenta Ito, Masanori Hirose, Yuji Wakayama, Koji Fukuda, Hiroaki Shimokawa.   

Abstract

BACKGROUND: The pathogenesis of out-of-hospital cardiac arrest (OHCA) without organic heart disease has not been fully investigated. METHODS AND
RESULTS: Induction tests were performed in 12 consecutive patients with OHCA for both coronary vasospasm with intracoronary acetylcholine and ventricular fibrillation (VF) with programmed stimulation at 1 month after the event. All patients were positive for 1 of the tests: coronary vasospasm alone in 3, VF alone in 2, and both in 7. All patients underwent implantable cardioverter defibrillator (ICD) implantation and appropriate ICD shock was documented in 1 patient.
CONCLUSIONS: OHCA has a heterogeneous pathogenesis and so dual induction tests are necessary.

Entities:  

Mesh:

Year:  2009        PMID: 19261991     DOI: 10.1253/circj.cj-09-0061

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  12 in total

1.  Complete definite positive spasm on acetylcholine spasm provocation tests: comparison of clinical positive spasm.

Authors:  Shozo Sueda; Toru Miyoshi; Yasuhiro Sasaki; Kousei Ohshima; Tomoki Sakaue; Hirokazu Habara; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2014-11-04       Impact factor: 2.037

2.  The real world in the clinic before and after the establishment of guidelines for coronary artery spasm: a questionnaire for members of the Japanese Cine-angio Association.

Authors:  Shozo Sueda; Hiroaki Kohno; Hideaki Yoshino
Journal:  Heart Vessels       Date:  2016-12-05       Impact factor: 2.037

3.  Relationships between more than 90% coronary luminal narrowing induced by ergonovine provocation test and ECG ischemic change as well as chest symptoms.

Authors:  Shozo Sueda; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2017-08-14       Impact factor: 2.037

4.  Feasibility of omitting provocation test with 50 μg of acetylcholine in left coronary artery.

Authors:  Yuichi Saito; Hideki Kitahara; Toshihiro Shoji; Satoshi Tokimasa; Takashi Nakayama; Kazumasa Sugimoto; Yoshihide Fujimoto; Yoshio Kobayashi
Journal:  Heart Vessels       Date:  2016-11-21       Impact factor: 2.037

5.  Paroxysmal atrial fibrillation during intracoronary acetylcholine provocation test.

Authors:  Yuichi Saito; Hideki Kitahara; Toshihiro Shoji; Satoshi Tokimasa; Takashi Nakayama; Kazumasa Sugimoto; Yoshihide Fujimoto; Yoshio Kobayashi
Journal:  Heart Vessels       Date:  2016-12-22       Impact factor: 2.037

6.  Current advances in the understanding of coronary vasospasm.

Authors:  Ming-Jui Hung
Journal:  World J Cardiol       Date:  2010-02-26

7.  Recurrent ventricular fibrillation under sufficient medical treatment in patient with coronary artery spasm.

Authors:  Masaru Hiki; Takashi Tokano; Yuji Nakazato; Hiroyuki Daida
Journal:  BMJ Case Rep       Date:  2013-07-02

8.  A case of Prinzmetal angina diagnosed by Holter monitoring who survived a sudden cardiac death: Case report.

Authors:  Ahmed Farah; Marc-Alexander Ohlow; Bettina Kühn; Markus Frommhold; Ulrich Lotze; J Christoph Geller; Bernward Lauer
Journal:  J Cardiol Cases       Date:  2012-07-21

Review 9.  Life-threatening arrhythmias leading to syncope in patients with vasospastic angina.

Authors:  Mitsuhiro Nishizaki
Journal:  J Arrhythm       Date:  2017-05-10

10.  Masked inherited primary arrhythmia syndromes in sudden cardiac death patients accompanied by coronary vasospasm.

Authors:  Ki Hong Lee; Hyung Wook Park; Jeong Nam Eun; Jeong Gwan Cho; Nam Sik Yoon; Mi Ran Kim; Yo Han Ku; Hyukjin Park; Seung Hun Lee; Jeong Han Kim; Min Chul Kim; Woo Jin Kim; Hyun Kuk Kim; Jae Yeong Cho; Keun-Ho Park; Doo Sun Sim; Hyun Ju Yoon; Kye Hun Kim; Young Joon Hong; Ju Han Kim; Youngkeun Ahn; Myung Ho Jeong; Jong Chun Park
Journal:  Korean J Intern Med       Date:  2017-08-11       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.